# TIFA

## Overview
TIFA, or TRAF-interacting protein with a forkhead-associated domain, is a gene that encodes a protein involved in critical immune signaling pathways. The protein, also referred to as TIFA, is characterized by its forkhead-associated (FHA) domain, which facilitates protein-protein interactions through the recognition of phosphorylated threonine and serine residues. As an adapter protein, TIFA plays a pivotal role in the activation of NF-κB and AP-1 transcription factors, which are essential for the innate immune response. It achieves this by forming oligomeric structures known as TIFAsomes, which enhance the assembly of signaling complexes, particularly with TRAF6, thereby promoting robust immune signaling. TIFA's involvement extends to various signaling pathways, including those activated by bacterial by-products and interleukin-1 (IL-1), underscoring its significance in both immune response and inflammation (Huang2012Intermolecular; Niederkorn2020TIFA; Takatsuna2003Identification).

## Structure
TIFA, or TRAF-interacting protein with a forkhead-associated domain, is a human protein involved in immune signaling pathways. The primary structure of TIFA consists of 184 amino acids and includes a conserved forkhead-associated (FHA) domain, which is crucial for recognizing phosphothreonine (pT) and phosphoserine residues (Shen2015TIFA; Niederkorn2020TIFA). The secondary structure of TIFA features a β-sandwich composed of a six-stranded β-sheet and a five-stranded β-sheet, a common feature of FHA domains (Huang2012Intermolecular).

The tertiary structure of TIFA reveals a dimeric form, with the dimer interface stabilized by van der Waals contacts and hydrogen bonding interactions (Nakamura2020Structural). This dimerization is intrinsic and serves as a basic unit for further oligomerization, which is essential for its function in signaling pathways (Huang2012Intermolecular). The quaternary structure involves the formation of higher-order oligomers, known as 'TIFAsomes,' which are critical for NF-κB pathway activation (Niederkorn2020TIFA).

Post-translational modifications, particularly the phosphorylation of threonine 9 (Thr9), play a significant role in TIFA's function. Phosphorylation at Thr9 facilitates TIFA oligomerization and the formation of a signaling complex with TRAF6, which is crucial for NF-κB activation (Nakamura2020Structural; Huang2012Intermolecular).

## Function
The TIFA protein, encoded by the TIFA gene, plays a crucial role in the innate immune response by activating NF-κB and AP-1 transcription factors. It is involved in the recognition of bacterial by-products, such as lipopolysaccharide (LPS) and heptose 1,7-bisphosphate, through a cytosolic surveillance pathway. This activation is essential for mounting an inflammatory response to recruit immune cells to sites of infection or tissue damage (Niederkorn2020TIFA).

TIFA contains a forkhead-associated (FHA) domain, which is important for its function in protein-protein interactions. The phosphorylation of threonine 9 (T9) on TIFA facilitates its oligomerization, forming structures known as TIFAsomes. These structures are critical for the activation of NF-κB, as they enhance the assembly of a signaling complex involving TRAF6, leading to robust immune signaling (Huang2012Intermolecular).

In addition to its role in immune signaling, TIFA acts as an adapter protein linking TRAF6 to IRAK-1 in IL-1 receptor signaling, further contributing to NF-κB activation. This interaction is dependent on IL-1 stimulation and highlights TIFA's role in linking various signaling pathways (Takatsuna2003Identification).

## Clinical Significance
Alterations in the expression of the TIFA gene have been implicated in various diseases and conditions. In acute myeloid leukemia (AML), elevated TIFA expression is associated with leukemic growth and chemoresistance, suggesting a role in disease progression (Niederkorn2020TIFA). In lung adenocarcinoma, high levels of TIFA correlate with poor survival outcomes, and its inhibition can lead to cell cycle arrest and apoptosis, indicating its potential as a therapeutic target (Niederkorn2020TIFA).

TIFA is also involved in the pathogenesis of pulmonary arterial hypertension (PAH), where increased expression in peripheral blood mononuclear cells is linked to elevated levels of pro-inflammatory cytokines IL-1β and TNF-α. This suggests that TIFA contributes to PAH development through inflammatory pathways (Chang2021TIFA).

In the context of Helicobacter pylori infection, TIFA plays a crucial role in the ALPK1/TIFA/NF-κB signaling axis, which is associated with DNA damage and replication stress in gastric epithelial cells. This pathway is linked to genomic instability and potentially carcinogenesis, highlighting TIFA's role in gastric cancer development (Bauer2020The).

## Interactions
TIFA, a TRAF-interacting protein with a forkhead-associated domain, is involved in several key protein interactions crucial for immune signaling. It interacts with TRAF6, a central player in the NF-κB signaling pathway, facilitating the formation of a TIFA-TRAF6 oligomeric complex that promotes TRAF6 ubiquitination and NF-κB activation (Nakamura2020Structural; Takatsuna2003Identification). TIFA also interacts with IRAK-1, enhancing its association with TRAF6 in the IL-1 receptor signaling pathway, which is essential for NF-κB and JNK pathway activation (Takatsuna2003Identification).

TIFA's role extends to the activation of the NLRP3 inflammasome, where it interacts with proteins such as NLRP3, ASC, and procaspase-1, acting as a nucleating particle to enhance inflammasome assembly (Lin2016TIFA). The phosphorylation of TIFA at Thr9 is critical for its oligomerization and interaction with these proteins, which is necessary for inflammasome activation and subsequent caspase-1-dependent pyroptosis (Pachathundikandi2018Heptose; Huang2012Intermolecular).

TIFA also forms higher-order structures known as 'TIFAsomes,' which are essential for robust innate immune activation through TRAF6 or TRAF2, allowing rapid signal amplification under sustained stimulation (Niederkorn2020TIFA). These interactions highlight TIFA's significant role in various signaling pathways and its potential as a target for therapeutic strategies in inflammatory and vascular diseases.


## References


[1. (Chang2021TIFA) Hao-Chih Chang, Tong-You Wade Wei, Pei-Yu Wu, Ming-Daw Tsai, Wen-Chung Yu, Chen-Huan Chen, and Shih-Hsien Sung. Tifa protein expression is associated with pulmonary arterial hypertension. Scientific Reports, July 2021. URL: http://dx.doi.org/10.1038/s41598-021-93582-1, doi:10.1038/s41598-021-93582-1. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-93582-1)

[2. (Bauer2020The) Michael Bauer, Zuzana Nascakova, Anca-Irina Mihai, Phil F. Cheng, Mitchell P. Levesque, Simon Lampart, Robert Hurwitz, Lennart Pfannkuch, Jana Dobrovolna, Melanie Jacobs, Sina Bartfeld, Anders Dohlman, Xiling Shen, Alevtina A. Gall, Nina R. Salama, Antonia Töpfer, Achim Weber, Thomas F. Meyer, Pavel Janscak, and Anne Müller. The alpk1/tifa/nf-κb axis links a bacterial carcinogen to r-loop-induced replication stress. Nature Communications, October 2020. URL: http://dx.doi.org/10.1038/s41467-020-18857-z, doi:10.1038/s41467-020-18857-z. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-18857-z)

[3. (Niederkorn2020TIFA) Madeline Niederkorn, Puneet Agarwal, and Daniel T. Starczynowski. Tifa and tifab: fha-domain proteins involved in inflammation, hematopoiesis, and disease. Experimental Hematology, 90:18–29, October 2020. URL: http://dx.doi.org/10.1016/j.exphem.2020.08.010, doi:10.1016/j.exphem.2020.08.010. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.exphem.2020.08.010)

[4. (Nakamura2020Structural) Teruya Nakamura, Chie Hashikawa, Kohtaro Okabe, Yuya Yokote, Mami Chirifu, Sachiko Toma-Fukai, Narushi Nakamura, Mihoko Matsuo, Miho Kamikariya, Yoshinari Okamoto, Jin Gohda, Taishin Akiyama, Kentaro Semba, Shinji Ikemizu, Masami Otsuka, Jun-ichiro Inoue, and Yuriko Yamagata. Structural analysis of tifa: insight into tifa-dependent signal transduction in innate immunity. Scientific Reports, March 2020. URL: http://dx.doi.org/10.1038/s41598-020-61972-6, doi:10.1038/s41598-020-61972-6. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-61972-6)

[5. (Takatsuna2003Identification) Hiroshi Takatsuna, Hiroki Kato, Jin Gohda, Taishin Akiyama, Ayaka Moriya, Yoshinari Okamoto, Yuriko Yamagata, Masami Otsuka, Kazuo Umezawa, Kentaro Semba, and Jun-ichiro Inoue. Identification of tifa as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (traf6) to interleukin-1 (il-1) receptor-associated kinase-1 (irak-1) in il-1 receptor signaling. Journal of Biological Chemistry, 278(14):12144–12150, April 2003. URL: http://dx.doi.org/10.1074/jbc.m300720200, doi:10.1074/jbc.m300720200. This article has 81 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m300720200)

[6. (Huang2012Intermolecular) Chia-Chi Flora Huang, Jui-Hung Weng, Tong-You Wade Wei, Pei-Yu Gabriel Wu, Pang-Hung Hsu, Yu-Hou Chen, Shun-Chang Wang, Dongyan Qin, Chin-Chun Hung, Shui-Tsung Chen, Andrew H.-J. Wang, John Y.-J. Shyy, and Ming-Daw Tsai. Intermolecular binding between tifa-fha and tifa-pt mediates tumor necrosis factor alpha stimulation and nf-κb activation. Molecular and Cellular Biology, 32(14):2664–2673, July 2012. URL: http://dx.doi.org/10.1128/mcb.00438-12, doi:10.1128/mcb.00438-12. This article has 42 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00438-12)

[7. (Shen2015TIFA) W Shen, A Chang, J Wang, W Zhou, R Gao, J Li, Y Xu, X Luo, R Xiang, N Luo, and D G Stupack. Tifa, an inflammatory signaling adaptor, is tumor suppressive for liver cancer. Oncogenesis, 4(10):e173–e173, October 2015. URL: http://dx.doi.org/10.1038/oncsis.2015.30, doi:10.1038/oncsis.2015.30. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/oncsis.2015.30)

[8. (Lin2016TIFA) Ting-Yang Lin, Tong-You Wade Wei, Shuai Li, Shen-Chih Wang, Ming He, Marcy Martin, Jiao Zhang, Tzu-Pin Shentu, Han Xiao, Jian Kang, Kuei-Chun Wang, Zhen Chen, Shu Chien, Ming-Daw Tsai, and John Y.-J. Shyy. Tifa as a crucial mediator for nlrp3 inflammasome. Proceedings of the National Academy of Sciences, 113(52):15078–15083, December 2016. URL: http://dx.doi.org/10.1073/pnas.1618773114, doi:10.1073/pnas.1618773114. This article has 50 citations.](https://doi.org/10.1073/pnas.1618773114)

[9. (Pachathundikandi2018Heptose) Kumar Pachathundikandi and Steffen Backert. Heptose 1,7-bisphosphate directed tifa oligomerization: a novel pamp-recognizing signaling platform in the control of bacterial infections. Gastroenterology, 154(4):778–783, March 2018. URL: http://dx.doi.org/10.1053/j.gastro.2018.01.009, doi:10.1053/j.gastro.2018.01.009. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2018.01.009)